SFX by Ex Libris Inc.

Title:	Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
Source:	Science [0036-8075] Maisonpierre, P C yr:1997

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Suri, C. "Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis." Cell 87.7 (1996): 1171-80.
description	2.	Valenzuela, D.M.. "Angiopoietins 3 and 4: diverging gene counterparts in mice and humans." Proceedings of the National Academy of Sciences of the United States of America 96.5: 1904-1909.
description	3.	Gale, Nicholas W W. "Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1." Developmental cell 3.3 (2002): 411-23.
description	4.	Zagzag, D. "Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis." Laboratory investigation 80.6 (2000): 837-849.
description	5.	Hanahan, D. "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis." Cell 86.3 (1996): 353-64.
description	6.	Risau, W. "Mechanisms of angiogenesis." Nature 386.6626 (1997): 671-674.
description	7.	Patan, S. "TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth." Microvascular Research 56.1 (1998): 1-21.
description	8.	Qin, Y. "Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation." Nature 376.6535 (1995): 70-4.
description	9.	Carmeliet, P. "Angiogenesis in cancer and other diseases." Nature 407.6801 (2000): 249-257.
description	10.	Christofori, G. "The angiogenic switch in carcinogenesis." Seminars in cancer biology 19.5 (2009): 329-337.
description	11.	FOLKMAN, J. "ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE." Nature medicine 1.1 (1995): 27-31.
description	12.	Olsen, Minna W B W. "Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure." Neoplasia 8.5 (2006): 364-72.
description	13.	Bergers, G. "Tumorigenesis and the angiogenic switch." Nature reviews. Cancer 3.6 (2003): 401-10.
description	14.	Yancopoulos, G D D. "Vascular-specific growth factors and blood vessel formation." Nature 407.6801 (2000): 242-8.
description	15.	Ferrara, N. "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo." Nature 362.6423: 841-844.
description	16.	Fiedler, U.. "Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation." Nature medicine 12.2 (2006): 235-239.
description	17.	Alitalo, K. "Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis." Developmental cell 3.3 (2002): 302-4.
description	18.	Yu, Q. "Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis." Cancer research 64.17 (2004): 6119-26.
description	19.	Saharinen, P. "Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cellâ€“cell and cellâ€“matrix contacts." Nature cell biology 10.5 (2008): 527-37.
description	20.	Saharinen, P.. "Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2." The Journal of cell biology 169.2: 239-243.